Samir Kapadia, MD

Appointed
2003

Education & Fellowships

Fellowship - Cleveland Clinic
Interventional Cardiology
Cleveland, OH
2000

Fellowship - Cleveland Clinic
Cardiology
Cleveland, OH
1998

Residency - Baylor College of Medicine
Internal Medicine
Houston, TX
1995

Medical Education - N.H.L.M. Medical College
Gujarat,
1990

Professional Highlights

• Director, Sones Cardiac Catheterization Laboratory
• Director, Interventional Cardiology Fellowship

Certifications

• Internal Medicine
• Internal Medicine - Cardiovascular Disease
• Internal Medicine - Interventional Cardiology

Specialty Interests

coronary interventions, percutaneous treatment of valvular heart disease, ASD/PFO closure, carotid interventions, peripheral interventions.

Awards & Honors

• 2007 Teacher of the Year Award, Interventional Cardiology, Cleveland Clinic
• 2006 Innovator Award, Cleveland Clinic
• 2006 Top Docs, Cleveland Magazine
• 2004 Top Docs, Cleveland Magazine
• 2000 Lower Clinical Award for Original Investigation and Professional Excellence in Scientific Paper, Cleveland Clinic
• 1999 Lower Clinical Award for Original Investigation and Professional Excellence in Scientific Paper, Cleveland Clinic
• 1998 Young Investigator Award for Clinical Research, Cardiovascular Young Investigator Forum, Astra Merck
• 1998 Peskind Memorial Award for Best Research Paper from Residents and Fellows Training in Division of Medicine, Cleveland Clinic
• 1998 First Place, Cardiology Research Day, Cleveland Clinic
• 1996 2nd Place, Basic Science Research, Research Symposium, Baylor College of Medicine
• 1995 Finalist, Melvin L. Marcus - Young Investigator Award in Cardiovascular Physiology, American Heart Association
• 1994 Best Basic Science Research Presentation, Baylor Scientific Symposium
• 1994 Outstanding Resident, Baylor College of Medicine
• 1989 Highest Honors, Final Academic Year, Medical School
• 1987 Merit Prize for exceptional performance, Indian Pharmacological Society
• 1987 Highest Honors, Second Academic Year, Medical School
• 1984 National Scholar, National Council of Educational Research & Training, India
• 1984 7th Rank (30,000 Premed Students), State Board, India
• 1982 6th Rank (250,000 Students), State Board, India

Innovations & Patents

• Devices for Percutaneous Valve Treatments

Memberships

• American Heart Association
• American College of Cardiology
• Society for Vascular Medicine

See publications for Samir Kapadia, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 9/18/2024, Dr. Kapadia has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Royalty Payments. Dr. Kapadia receives or has the right to receive royalty payments for inventions or discoveries commercialized through the companies shown below:

• Mitria Medical, LLC
• Bavaria Medizin Technologie GmbH

Right to Future Distribution of Cleveland Clinic Financial Interest. Dr. Kapadia may receive future financial benefits from the Cleveland Clinic for inventions or discoveries commercialized through the companies shown below:

• Bavaria Medizin Technologie GmbH
• Mitria Medical, LLC

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.